Randomized phase II trial of presurgical androgen deprivation therapy (ADT) with or without axitinib in prostate cancer (PCa) presenting with lymph node (LN) metastasis.

被引：0
|
作者：
Zurita, Amado J.
Tidwell, Rebecca Slack
Troncoso, Patricia
Chapin, Brian Francis
Harris, Deborah
Pisters, Louis L.
Araujo, John C.
Pettaway, Curtis Alvin
Aparicio, Ana
Tu, Shi-Ming
Papadopoulos, John N.
Wang, Jennifer
Logothetis, Christopher
Pagliaro, Lance C.
Davis, John W.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Div Canc Med, Houston, TX 77030 USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.5078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5078
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer
    D'Amico, Anthony V.
    Chen, Ming-Hui
    Renshaw, Andrew
    Loffredo, Marian
    Kantoff, Philip W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (12): : 1291 - 1293
  • [42] Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
    D'Amico, Anthony, V
    Xie, Wanling
    McMahon, Elizabeth
    Loffredo, Marian
    Medeiros, Shana
    Joseph, David
    Denham, Jim
    Kumar, Parvesh
    Bubley, Glenn
    Sullivan, Molly
    Hellwig, Richard
    Vera, Juan Carlos
    Freter, Rolf
    Baker, W. Jeffrey
    Wong, Jeffrey Y.
    Renshaw, Andrew A.
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2938 - +
  • [43] Androgen deprivation therapy (ADT) plus docetaxel (D) versus ADT alone for hormone-naive metastatic prostate cancer (PCa): Long-term analysis of the GETUG-AFU 15 phase III trial.
    Gravis, Gwenaelle
    Boher, Jean-Marie
    Joly, Florence
    Oudard, Stephane
    Albiges, Laurence
    Priou, Franck
    Latorzeff, Igor
    Delva, Remy
    Krakowski, Ivan
    Laguerre, Brigitte
    Rolland, Frederic
    Theodore, Christine
    Deplanque, Gael
    Ferrero, Jean-Marc
    Pouessel, Damien
    Mourey, Loic
    Beuzeboc, Philippe
    Habibian, Muriel
    Soulie, Michel
    Fizazi, Karim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [44] SURVIVAL ANALYSIS OF A RANDOMIZED PHASE III TRIAL COMPARING ANDROGEN DEPRIVATION THERAPY (ADT) PLUS DOCETAXEL VERSUS ADT ALONE IN HORMONE-SENSITIVE METASTATIC PROSTATE CANCER (GETUG-AFU 15/0403)
    Gravis, G.
    Fizazi, K.
    Lobbedez, F. Joly
    Oudard, S.
    Priou, F.
    Latorzeff, I.
    Delva, R.
    Krakowski, I.
    Laguerre, B.
    Rolland, F.
    Theodore, C.
    Deplanque, G.
    Ferrero, J. M.
    Pouessel, D.
    Mourey, L.
    Beuzeboc, P.
    Zanetta, S.
    Esterni, B.
    Habibian, M.
    Soulie, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 294 - 294
  • [45] Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized Trial
    Antonarakis, Emmanuel S.
    Kibel, Adam S.
    Yu, Evan Y.
    Karsh, Lawrence I.
    Elfiky, Aymen
    Shore, Neal D.
    Vogelzang, Nicholas J.
    Corman, John M.
    Millard, Frederick E.
    Maher, Johnathan C.
    Chang, Nancy N.
    DeVries, Todd
    Sheikh, Nadeem A.
    Drake, Charles G.
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2451 - 2459
  • [46] Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
    McKay, Rana R.
    Xie, Wanling
    Ye, Huihui
    Fennessy, Fiona M.
    Zhang, Zhenwei
    Lis, Rosina
    Calagua, Carla
    Rathkopf, Dana
    Laudone, Vincent P.
    Bubley, Glenn J.
    Einstein, David J.
    Chang, Peter K.
    Wagner, Andrew A.
    Parsons, J. Kellogg
    Preston, Mark A.
    Kilbridge, Kerry
    Chang, Steven L.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Taplin, Mary-Ellen
    JOURNAL OF UROLOGY, 2021, 206 (01) : 80 - 87
  • [47] A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy
    Lang, Joshua M.
    Wallace, Marianne
    Becker, Jordan T.
    Eickhoff, Jens C.
    Buehring, Bjoern
    Binkley, Neil
    Staab, Mary Jane
    Wilding, George
    Liu, Glenn
    Malkovsky, Miroslav
    McNeel, Douglas G.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 407 - 415
  • [48] Metformin for Prevention of Anthropometric and Metabolic Complications of Androgen Deprivation Therapy in Prostate Cancer Patients Receiving Radical Radiotherapy: A Phase II Randomized Controlled Trial
    Usmani, Nawaid
    Ghosh, Sunita
    Sanghera, Karan P.
    Ong, Aldrich D.
    Koul, Rashmi
    Dubey, Arbind
    Ahmed, Shahida
    Quon, Harvey
    Yee, Don
    Parliament, Matthew
    Sivananthan, Gokulan
    Hunter, William
    Danielson, Brita
    Rowe, Lindsay
    McDonald, Megan
    Kim, Julian O.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (02): : 317 - 326
  • [49] The effects of a preference-based exercise trial on outcomes in men on androgen deprivation therapy (ADT) for prostate cancer compared to an exercise randomized controlled trial of the same interventions.
    Alibhai, Shabbir M. H.
    Papadopoulos, Efthymios
    Tomlinson, George
    Durbano, Sara
    Mina, Daniel Santa
    Sabiston, Catherine
    Matthew, Andrew
    Ritvo, Paul
    Chiarotto, James Anthony
    Sidani, Souraya
    Culos-Reed, S. Nicole
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [50] A randomized placebo-controlled trial of daily high-dose oral risedronate in men with metastatic prostate cancer commencing androgen deprivation therapy (ADT)
    Sweeney, C.
    Dugan, W. M., II
    Dreicer, R.
    Chu, F.
    Parks, G.
    Baker, K.
    Reed, D.
    Jansz, K.
    Zadra, J.
    Yiannoutsos, C. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345